Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-08-24

Clinical Trial Update: Hepatic Arterial Infusion With FOLFOX Alone or in Combination With IV Chemotherapy in Colon Cancer With Liver Metastasis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating hepatic arterial infusion with FOLFOX alone or with IV chemotherapy for metastatic colorectal cancer with liver metastases has been w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-Fluorouracil (5-FU)
  • Leucovorin (folinic acid)
  • OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Western Regional Medical Center | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: WITHDRAWN